Hormonal therapies up-regulate MANF and overcome female susceptibility to immune checkpoint inhibitor myocarditis

Zhang, YH; Sun, CC; Li, YJ; Qin, J; Amancherla, K; Jing, Y; Hu, QS; Liang, K; Zhang, Z; Ye, YQ; Huang, LA; Nguyen, TK; Egranov, SD; Zhao, ZL; Wu, A; Xi, YT; Yao, J; Hung, MC; Calin, GA; Cheng, J; Lim, B; Lehmann, LH; Salem, JE; Johnson, DB; Curran, MA; Yu, DH; Han, L; Darabi, R; Yang, LQ; Moslehi, JJ; Lin, C

Zhang, YH; Yang, LQ; Lin, C (通讯作者),Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.;Zhang, YH (通讯作者),Capital Med Univ, Beijing Inst Brain Disorders, Collaborat Innovat Ctr Brain Disorders, Beijing 10069, Peoples R China.;Moslehi, JJ (通讯作者),Univ Calif San Francisco, Div Cardiol, Sect Cardio Oncol & Immunol, San Francisco, CA 94143 USA.;Moslehi, JJ (通讯作者),Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.;Yang, LQ; Lin, C (通讯作者),Univ Texas

SCIENCE TRANSLATIONAL MEDICINE, 2022; 14 (669):

Abstract

Immune checkpoint inhibitors (ICIs) have been increasingly used in combination for cancer treatment but are associated with myocarditis. Here, we repo......

Full Text Link